Skip to main content

Table 1 Demographics

From: Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study [ISRCTN23032971].

 

Treatment groups

 

Demographic Characteristics

AM-group (n = 336)

PM-group (n = 327)

p-value

Age (years)

   

Mean (SD)

35.4 (11.0)

36.5 (12.0)

0.232a

Min-Max

18–69

18–75

 

Age Group (years)

   

18–29

115 (34.2 %)

113 (34.6 %)

 

30–39

113 (33.6 %)

95 (29.1 %)

 

40–49

70 (20.8 %)

66 (20.2 %)

 

≥ 50

38 (11.3 %)

53 (16.2 %)

 

Sex

   

Male (%)

152 (45)

163 (50)

0.235b

Female (%)

184 (55)

164 (50)

 

Duration of SAR History (years)

   

Mean (SD)

14.2 (9.2)

14.4 (10.3)

0.662a

Min-Max

2–50

1–55c

 
  1. a t-test for differences between the means of the two treatment groups
  2. b χ2-test for the distribution between the two groups
  3. c One patient in the PM-group had only one year duration of SAR history although the inclusion criterion was 2 years